Head and Neck Squamous Cell Carcinoma (HNSCC) Completed Phase 2 Trials for DB11666 (Buparlisib)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01852292Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum TherapyTreatment